Retatrutide is a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By stimulating these receptors, https://miriamwybl110296.topbloghub.com/42604388/retatrutide-a-promising-new-treatment-for-obesity